Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,089 JPY | -0.02% | +0.49% | +0.86% |
26/04 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
26/04 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
ETFs positioned on Takeda Pharmaceutical Company Limited
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
24.44% | 15 M€ | +7.34% | ||
5.00% | 284 M€ | +23.00% | ||
3.80% | 1,552 M€ | +18.10% | ||
3.43% | 251 M€ | +13.17% | ||
3.26% | 57 M€ | +19.27% | ||
1.68% | 14 M€ | +15.63% | ||
1.65% | 10,207 M€ | +14.32% | ||
1.65% | 5,115 M€ | +13.58% | ||
1.50% | 73 M€ | +11.61% | ||
1.38% | 18 M€ | +16.15% | - | |
1.38% | 66,066 M€ | +14.68% | - | |
1.38% | 20,721 M€ | +13.52% | - | |
1.38% | 144,586 M€ | +14.49% | ||
1.34% | 26 M€ | +20.62% | ||
0.79% | 5 M€ | -.--% | - | |
0.54% | 16,729 M€ | +13.38% | - | |
0.53% | 31,732 M€ | +14.31% | - | |
0.53% | 1,198 M€ | +13.48% | - | |
0.50% | 26 M€ | +2.00% | - | |
0.46% | 717 M€ | +6.20% | ||
0.44% | 4 M€ | +13.95% | ||
0.43% | 67,864 M€ | +14.28% | ||
0.35% | 36 M€ | +1.20% | - | |
0.27% | 10 M€ | -3.35% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.86% | 40.76B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 4502 Stock
- Funds and ETFs Takeda Pharmaceutical Company Limited